FR817M - - Google Patents
Info
- Publication number
- FR817M FR817M FR847895A FR847895A FR817M FR 817 M FR817 M FR 817M FR 847895 A FR847895 A FR 847895A FR 847895 A FR847895 A FR 847895A FR 817 M FR817 M FR 817M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55149A US3070498A (en) | 1960-09-12 | 1960-09-12 | Nitrothiazole-hydroxyquinoline compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
FR817M true FR817M (ja) | 1961-09-18 |
Family
ID=21995944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR847895A Active FR817M (ja) | 1960-09-12 | 1960-12-23 |
Country Status (3)
Country | Link |
---|---|
US (1) | US3070498A (ja) |
FR (1) | FR817M (ja) |
GB (1) | GB899992A (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1635847B1 (en) * | 2003-06-13 | 2019-07-31 | IDH Holding ApS | Treatment of symptoms associated with bacterial vaginosis |
GB0507490D0 (en) * | 2005-04-14 | 2005-05-18 | Aq & Plc | Treatment of animal parasites |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA558019A (en) * | 1958-05-27 | Merck And Co. Inc. | Therapeutic composition containing 2-amino-5-nitrothiazole | |
CA524353A (en) * | 1956-04-24 | The Wellcome Foundation Limited | Antitrichomonal pessary | |
US2675389A (en) * | 1952-01-09 | 1954-04-13 | Geza S Delmar | Arsanilate salts of hydroxyquinolines |
-
1960
- 1960-09-12 US US55149A patent/US3070498A/en not_active Expired - Lifetime
- 1960-12-23 FR FR847895A patent/FR817M/fr active Active
- 1960-12-28 GB GB44471/60A patent/GB899992A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
US3070498A (en) | 1962-12-25 |
GB899992A (en) | 1962-06-27 |